Westlake Pharma

Westlake Therapeutics is a clinical-stage biotechnology company specializing in the development of engineered red blood cell (RBC) therapies. Utilizing its proprietary REDx platform, the company engineers red blood cells to carry therapeutic payloads, including proteins, small molecules, and nucleic acids, to treat cancer, metabolic diseases, and autoimmune disorders. Their lead programs focus on oncology and rare metabolic conditions like gout and phenylketonuria. By leveraging the long circulatory lifespan and low immunogenicity of RBCs, Westlake Therapeutics aims to provide safer and more durable treatment options compared to traditional cell therapies.